{"id":"W2981487409","doi":"10.3747/co.26.4957","title":"Descriptive Analysis of Dosing and Outcomes for Patients with Ibrutinib-Treated Relapsed or Refractory Chronic Lymphocytic Leukemia in a Canadian Centre","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Ibrutinib; Medicine; Dosing; Chronic lymphocytic leukemia; Refractory (planetary science); Internal medicine; Oncology; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002699193,0.000230752,0.001010633,0.001009069,0.00004430994,0.00001032976,0.0001219721,0.0002058201,0.0001824981],"category_scores_gemma":[0.0003807268,0.0001632064,0.0001136267,0.0009654404,0.0001832734,0.00008434794,0.00005237457,0.0002205876,0.00000987475],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2101931,"about_ca_system_score_gemma":0.06453784,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.09623371,"about_ca_topic_score_gemma":0.2911066,"domain_scores_codex":[0.9979278,0.0001083372,0.0004657187,0.0004871625,0.0002760807,0.0007349246],"domain_scores_gemma":[0.9981908,0.000578729,0.0001958553,0.0003714923,0.0002893002,0.0003738216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002833703,0.0001716814,0.9833767,0.000463171,0.0009375242,0.00004738146,0.001352091,0.0002050732,0.00006237069,0.00003773922,0.0001867543,0.01032577],"study_design_scores_gemma":[0.1261004,0.006095907,0.725185,0.0007871115,0.002717124,0.00001849507,0.000865525,0.1243289,0.0001489816,0.00001006292,0.0132625,0.0004799855],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997385,0.0004508578,0.000006584063,0.00004897802,0.0001925224,0.001558873,0.00008012402,0.00001828713,0.0002588186],"genre_scores_gemma":[0.9990475,0.0001004482,0.0001244001,0.00003568617,0.00002320397,0.00004645003,0.0002610163,0.00002935337,0.0003319142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2581918,"threshold_uncertainty_score":0.9407654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04108176699538796,"score_gpt":0.3552572270065208,"score_spread":0.3141754600111328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}